Home » Topics » Regulatory » Patents

Patents
RSS

JT discloses new compounds for Alzheimer's disease and other CNS disorders

Dec. 4, 1996

New endothelin receptor modulators reported by Texas Biotechnology

Dec. 4, 1996

EGFR tyrosine kinase inhibitors from Ciba-Geigy for hyperproliferative conditions

Dec. 4, 1996

PDE IV inhibitors/cytokine inhibitors disclosed by Janssen

Dec. 4, 1996

New 5-HT1D antagonists from SmithKline Beecham

Dec. 4, 1996

McNeil describes new antipsychotic compounds

Dec. 4, 1996

New azole antifungal agents described by Zambon

Dec. 4, 1996

Bronchoselective beta-adrenergic agonists reported by Almirall

Dec. 4, 1996

Cathepsin B and L inhibitors described by Nippon Chemiphar

Dec. 3, 1996

COX-2 inhibitors under investigation at Glaxo Wellcome

Dec. 3, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 21, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...